Table 2 Characteristics of HIV-1 negative controls and HIV-1 infected patients with colorectal tissue biopsies
HIV status/patient ID | Gender | Age (years) | Comorbidities | CD4+ T cell count (cells/μl) | Plasma viral load (copies/ml) | cART regimen |
|---|---|---|---|---|---|---|
HIV-1 negative controls (n = 7) | ||||||
 0057 | M | 49 | Colon polyp | NA | NA | NA |
 7403 | M | 48 | Rectum polyp | NA | NA | NA |
 7435 | M | 55 | Colon polyp | NA | NA | NA |
 7559 | F | 70 | Colon polyp | NA | NA | NA |
 7582 | F | 50 | Colon polyp | NA | NA | NA |
 7590 | M | 46 | Colon polyp | NA | NA | NA |
 7894 | F | 54 | Colon polyp | NA | NA | NA |
HIV-1 infected patients (n = 7) | ||||||
 0118 | F | 40 | Colon cancer | 435 |  < LOD | 3TC/AZT/EFV |
 0128 | M | 55 | Rectum cancer | 86 | 693,800 | Untreated |
 0129 | F | 61 | Colon cancer | 246 |  < LOD | 3TC/AZT/EFV |
 0288 | M | 36 | Colon cancer | 119 |  < LOD | 3TC/AZT/NVP |
 0293 | M | 63 | Colon cancer | 327 | 172,500 | Untreated |
 0295 | M | 31 | Colon cancer | 913 |  < LOD | 3TC/EFV/TDF |
 0316 | F | 53 | Colon cancer | 338 |  < LOD | 3TC/EFV/TDF |